Laser TP, a common treatment for glaucoma,
induces sustained matrix MMP expression within the juxtacanalicular
region of the aqueous humor outflow pathway. Since these MMPs increase
aqueous humor outflow facility, this can explain the efficacy of this
treatment for glaucoma. Bradley et al. (p. 422) found that, within 8
hours following laser treatment, trabecular IL-1α, IL-1β, and
TNFα are increased, and that the latter two are secreted. These
cytokines are strong stimulators of trabecular MMP expression.
Furthermore, adding the IL-1 receptor antagonist or TNFα-blocking
antibodies to culture medium from laser-treated anterior segments
eliminates the MMP induction. Thus, secreted IL-1β and TNFα may
mediate the MMP response and the efficacy of laser TP in glaucoma.